Midland Wealth Advisors LLC increased its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 2.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 7,365 shares of the company’s stock after buying an additional 197 shares during the quarter. Midland Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $670,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Chicago Partners Investment Group LLC boosted its holdings in shares of Colgate-Palmolive by 16.2% in the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after acquiring an additional 943 shares in the last quarter. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at $1,315,000. Carrera Capital Advisors increased its position in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares during the period. Fiduciary Alliance LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $4,066,000. Finally, Impact Partnership Wealth LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth $803,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Ratings Changes
Several research analysts recently weighed in on the company. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, March 3rd. UBS Group reduced their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. TD Cowen cut their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $101.61.
Colgate-Palmolive Stock Up 3.8 %
Shares of CL stock opened at $96.84 on Monday. The stock’s 50 day simple moving average is $88.84 and its 200 day simple moving average is $95.11. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a market capitalization of $78.59 billion, a price-to-earnings ratio of 27.51, a PEG ratio of 4.20 and a beta of 0.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the business earned $0.87 earnings per share. As a group, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Top Biotech Stocks: Exploring Innovation Opportunities
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.